About Benign Peripheral Nerve Tumor
A benign peripheral nerve tumor is a non-cancerous growth that develops in the sheath surrounding the peripheral nerves. It can develop due to a variety of causes. Some of the known causes include:
- Genetic disorders: In some cases, benign peripheral nerve tumors are caused by genetic disorders such as neurofibromatosis 2 (NF2), Schwannomatosis, or Carney complex. People with these genetic disorders usually have more than one benign schwannoma.
Non-modifiable risk factors are factors that cannot be changed or controlled. If a person has a genetic disorder such as neurofibromatosis 2 (NF2), they have an increased risk of developing benign peripheral nerve tumors.
Modifiable risk factors are factors that can be changed or controlled. While there is limited information available on modifiable risk factors for benign peripheral nerve tumors, some risk factors have been identified for malignant peripheral nerve sheath tumors (MPNSTs). These risk factors may also apply to benign peripheral nerve tumors:
- Radiation exposure: Exposure to ionizing radiation prior in life has been associated with an increased risk of developing certain types of nerve tumors, including MPNSTs. Ionizing radiation can induce genetic alterations that may contribute to tumor development.
It's important to note that the information available on modifiable risk factors for benign peripheral nerve tumors is limited, and further research is needed to better understand these factors and their impact on tumor development.
Benign peripheral nerve tumors, such as neurofibromas and schwannomas, can have different symptoms depending on the stage, progression, or severity of the tumor.
Here are the most common early symptoms of a benign peripheral nerve tumor:
- Irradiating pain provoked by pressure at the tumor site
- Weakness or abnormal sensations like tingling or numbness
Other common symptoms that may occur with later stages, progression, or higher severity of a benign peripheral nerve tumor include:
- Painful mass: This mass can be felt and may be associated with tenderness.
- Tinel sign: Tinel sign refers to a tingling sensation or electric shock-like feeling that occurs when tapping or pressing on the affected area.
- Nerve damage: As the tumor progresses or becomes more severe, it can lead to weakness in the affected area and changes in sensation.
- Peripheral neuropathy: This is a condition that affects the nerves outside of the brain and spinal cord. Symptoms include numbness, tingling, muscle weakness, and difficulty with coordination.
- Changes in electrophysiological results: This means that tests used to measure nerve function may show abnormalities in amplitude (the strength of electrical signals).
- Tumor size and growth rate: Benign peripheral nerve tumors typically grow slowly over years. However, in some cases, they can grow faster within weeks to months.
When diagnosing a benign peripheral nerve tumor, health care providers may perform several examinations, tests, and procedures. These include:
- Physical Exam: During the physical exam, the health care provider will look for physical signs of a medical problem, such as pain, swelling, or the presence of masses within the body.
- Lab Tests: Specific lab tests, like a blood draw, may be recommended by your health care provider. These tests check samples of your blood, urine, or body tissues to help diagnose the disease.
- Imaging Studies: Health care providers may recommend imaging studies such as X-rays or MRIs. These diagnostic imaging studies allow doctors to look inside your body for clues to help diagnose or manage the disease. The type of imaging study chosen depends on your symptoms and the part of the body being examined.
Additional procedures that can be performed to determine the stage or severity of a benign peripheral nerve tumor include:
- Clinical Procedures: These can include a range of different tests depending on the body system being evaluated.
- Whole-Body MRI: This procedure is frequently used for staging and follow-up in patients with neurofibromatosis. It helps determine the exact localization, size, and extent of benign and malignant nerve tumors for visualization of tumor-related complications and therapy planning.
- High-Resolution Ultrasound (HRUS): HRUS is a well-established method for examining peripheral nerves. It has been shown to have high value in diagnosing and planning therapy for nerve trauma, polyneuropathies, mononeuritis, and nerve tumors.
It's important to note that some procedures may be performed on an outpatient basis and may require a referral from your primary care provider (PCP). If your symptoms worsen or change after any examination or procedure, it is important to follow up with your health care provider for further evaluation and guidance.
Remember that each individual's diagnostic journey may vary depending on their specific symptoms and medical history. It's always best to consult with a health care provider to determine which examinations, tests, or procedures are most appropriate for you.
The goals of treatment are to remove the tumor, preserve neurological function, and improve symptoms and disability. Here are the different treatment options and how they work to achieve these goals:
- Surgery: The goal is to completely remove the tumor while preserving healthy nerve fibers and neurological function. The success of surgery depends on the location of the tumor and the expertise of the surgeon.
- Radiation therapy: Radiation therapy may be used as a primary treatment or in combination with surgery. It aims to destroy remaining tumor cells after surgery or to control tumor growth when surgery is not possible. Even so, it does not guarantee complete removal of the tumor.
- Medication: Medications are not typically used as a primary treatment for benign peripheral nerve tumors. However, there are ongoing clinical trials investigating targeted therapies for specific types of tumors. These targeted therapies aim to reduce tumor burden and improve outcomes, but more research is needed to determine their efficacy. In certain cases of malignant transformation or when there is a risk of recurrence after surgery chemotherapeutic drugs may be used.
- Health maintenance: It's important for individuals with these tumors to maintain overall good health by following a balanced diet, engaging in regular physical activity, managing stress levels, and getting enough restful sleep. These general healthy lifestyle practices can support overall well-being during treatment.
It's important to note that the specific treatment approach for benign peripheral nerve tumors may vary depending on individual factors such as tumor size, location, and overall health. It may be necessary to consult with various specialists, including peripheral nerve surgeons and other relevant healthcare professionals, to ensure comprehensive care and optimal outcomes for patients.
Remember to always consult with your doctor before considering any home remedies or over-the-counter medications for benign peripheral nerve tumors or any other medical condition.
Benign peripheral nerve tumors, such as neurofibromas and schwannomas, can have a variable natural progression over time. The specific progression depends on factors like the type of tumor and individual characteristics. However, it is important to note that most benign peripheral nerve tumors grow slowly and are non-cancerous.
Complications commonly associated with benign peripheral nerve tumors can include:
- Neurological impairments: These impairments can include sensorimotor deficits or pain that may affect daily activities and quality of life.
- Local complications: Tumor growth and presence can cause compression of nearby structures like nerves, blood vessels, or organs, leading to symptoms like pain, numbness, or weakness.
- Malignant transformation: While rare, there is a small risk that benign peripheral nerve tumors may transform into malignant peripheral nerve sheath tumors (MPNSTs). MPNSTs are cancerous and require more aggressive treatment.
If your symptoms worsen or change it is important to follow up with your health care provider for further evaluation and guidance.